October 2019 Digest
Since 2002, the Life Science Industry Awards recognize the innovative manufacturers of the “tools of science” that help advance biological research and drug discovery. Traditionally, the Life Science Industry Awards have been a bi-annual event where thousands of life scientists nominate and vote for the best performing supplier in 10 distinct customer support, service and communications categories.
This year, the Life Science Industry Awards have expanded to include three new categories to recognize the most innovative new products released this year. Winners will be selected by the editors of Instrument Business Outlook and the scientists who comprise BioInformatics’ market insights team.
The winners of the new Life Science Industry Awards – Innovation will be announced via a webinar on November 20th, 2019
Sample Preparation for Next-Generation Sequencing: Nucleic Acid Preparation, Fragmentation, and Library Preparation
Next Generation Sequencing (NGS) is the chief technology that has enabled the advance of precision medicine, which aims to tailor medical treatments to the individual characteristics of each patient and their disease by taking into account genetic and biomarker traits. Demand for sequencing, and by necessity demand for preanalytical NGS sample preparation, is rapidly expanding, growing at a double-digit pace. This report provides an in-depth look at the sequencing market, including data for 2018-2023.
RateMyProduct Webinar
This webinar will demonstrate how RateMyProduct works, its ease-of-use, benefits, the timeline, and the reporting you will receive. RateMyProduct enables life science marketing and product managers to test their new product ideas against a database of norms created from other products evaluated and obtain critical insights at a low cost.
Click here to listen to the webinar
Promo: Free Issue of Instrument Business Outlook
Sign up to get a promo code!
Precision Medicine Bringing Sequencing to the Clinical Lab
Sequencing has been the driving technology to make this possible, both in terms of diagnosis, and the development of targeted therapies. Next-generation sequencing (NGS) has had an enormous impact on life sciences and medicine since its commercialization over a decade ago. As the technology has matured and become more accessible and affordable, the use of NGS has expanded beyond the lab to the medical diagnostics space.
Click here to read the full article
Trending from Instrument Business Outlook: NGS-based Dataset Continues NIST’s Efforts to Support the Forensic DNA Community
Last year, the National Institute of Standards and Technology (NIST) announced that it had developed a “statistical foundation” for analyzing match statistics with NGS, leading to more detailed DNA profiles to help solve crimes. In order to produce a conventional DNA profile, labs examine genetic markers called short tandem repeats (STRs)….
Click here to read the complete article
